Myxoinflammatory Fibroblastic Sarcoma.
Wu H, Laskin WB.
Surg Pathol Clin. 2024 Mar;17(1):83-96. doi: 10.1016/j.path.2023.07.003. Epub 2023 Aug 8.
Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy.
Zboralski D, Hoehne A, Bredenbeck A, Schumann A, Nguyen M, Schneider E, Ungewiss J, Paschke M, Haase C, von Hacht JL, Kwan T, Lin KK, Lenore J, Harding TC, Xiao J, Simmons AD, Mohan AM, Beindorff N, Reineke U, Smerling C, Osterkamp F.
Eur J Nucl Med Mol Imaging. 2022 Sep;49(11):3651-3667. doi: 10.1007/s00259-022-05842-5. Epub 2022 May 24.
Exploiting LRRC15 as a Novel Therapeutic Target in Cancer.
Ray U, Pathoulas CL, Thirusangu P, Purcell JW, Kannan N, Shridhar V.
Cancer Res. 2022 May 3;82(9):1675-1681. doi: 10.1158/0008-5472.CAN-21-3734.
LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody-Drug Conjugates.
Purcell JW, Tanlimco SG, Hickson J, Fox M, Sho M, Durkin L, Uziel T, Powers R, Foster K, McGonigal T, Kumar S, Samayoa J, Zhang D, Palma JP, Mishra S, Hollenbaugh D, Gish K, Morgan-Lappe SE, Hsi ED, Chao DT.
Cancer Res. 2018 Jul 15;78(14):4059-4072. doi: 10.1158/0008-5472.CAN-18-0327. Epub 2018 May 15.
Myofibrosarcoma.
Fisher C.
Virchows Arch. 2004 Sep;445(3):215-23. doi: 10.1007/s00428-004-1038-9. Epub 2004 Jun 2.
Fibroblastic variant of low-grade endometrial stromal sarcoma mimicking an inflammatory pseudotumor: a case report.
Haloui A, Karich N, Miry A, Bennani A.
Pan Afr Med J. 2022 Sep 21;43:34. doi: 10.11604/pamj.2022.43.34.29749. eCollection 2022.
Proteomic analysis of pleomorphic dermal sarcoma reveals a fibroblastic cell of origin and distinct immune evasion mechanisms.
Klein S, Tolkach Y, Reinhardt HC, Buettner R, Quaas A, Helbig D.
Sci Rep. 2024 May 31;14(1):12516. doi: 10.1038/s41598-024-62927-x.
Metabolic targeting of cancer associated fibroblasts overcomes T-cell exclusion and chemoresistance in soft-tissue sarcomas.
Broz MT, Ko EY, Ishaya K, Xiao J, De Simone M, Hoi XP, Piras R, Gala B, Tessaro FHG, Karlstaedt A, Orsulic S, Lund AW, Chan KS, Guarnerio J.
Nat Commun. 2024 Mar 20;15(1):2498. doi: 10.1038/s41467-024-46504-4.
Contemporary diagnostics: sarcoma pathology update.
Brooks JS, Lee S.
J Surg Oncol. 2015 Apr;111(5):513-9. doi: 10.1002/jso.23853. Epub 2015 Feb 17.
Myxoid Inflammatory Myofibroblastic Sarcoma: Clinicopathologic Analysis of 25 Cases of a Distinctive Sarcoma With Deceptively Bland Morphology and Aggressive Clinical Behavior.
Papke DJ Jr, Odintsov I, Dickson BC, Nucci MR, Agaimy A, Fletcher CDM.
Am J Surg Pathol. 2024 Aug 1;48(8):1005-1016. doi: 10.1097/PAS.0000000000002231. Epub 2024 May 8.
